MICHELLE BURRIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHELLE BURRIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHELLE BURRIS. MICHELLE BURRIS is Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and in Acer Therapeutics Inc. ($OPXA) and Director in Acer Therapeutics Inc. ($ACER) and Director in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and Director in PHASERX, INC. ($PZRX) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT).
Latest Insider Trading Transactions of MICHELLE BURRIS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACER, ACHV, ADPT, ADRO, HTGM, PZRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 2,500 | 19,500 | 76,000 | |
| May 19 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 35.00 | 2,500 | 87,500 | 1,504 | 4 K to 1.5 K (-62.44 %) |
| May 19 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 2,500 | 19,500 | 4,004 | 1.5 K to 4 K (+166.22 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 4,500 | 35,100 | 78,500 | |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 43.41 | 4,500 | 195,345 | 1,504 | 6 K to 1.5 K (-74.95 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 4,500 | 35,100 | 6,004 | 1.5 K to 6 K (+299.20 %) |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 89,000 | |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 66.50 | 3,759 | 249,974 | 3,759 | |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 65.08 | 6,000 | 390,480 | 1,504 | 7.5 K to 1.5 K (-79.96 %) |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 7,504 | 1.5 K to 7.5 K (+398.94 %) |
| Feb 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Grant | A | 0.00 | 1,504 | 0 | 1,504 | 0 to 1.5 K |
| Jan 20 2021 | ACER | Acer Therapeutics ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 3.85 | 15,000 | 57,750 | 15,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 95,000 | |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 66.43 | 959 | 63,706 | 0 | 959 to 0 (-100.00 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 65.77 | 5,041 | 331,547 | 959 | 6 K to 959 (-84.02 %) |
| Jan 15 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 6,000 | 0 to 6 K |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 6,000 | 46,800 | 101,000 | |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 59.44 | 1,651 | 98,135 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 58.96 | 3,367 | 198,518 | 1,651 | 5 K to 1.7 K (-67.10 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 57.42 | 982 | 56,386 | 5,018 | 6 K to 5 K (-16.37 %) |
| Dec 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 6,000 | 46,800 | 6,000 | 0 to 6 K |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 12,000 | 93,600 | 113,000 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 53.07 | 7,351 | 390,118 | 0 | 7.4 K to 0 (-100.00 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 52.48 | 4,649 | 243,980 | 7,351 | 12 K to 7.4 K (-38.74 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 12,000 | 93,600 | 12,000 | 0 to 12 K |
| Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
| Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 14.77 | 23,522 | 347,420 | 23,522 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Feb 18 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 31.71 | 8,888 | 281,838 | 8,888 | |
| Jan 03 2020 | ACER | Acer Therapeutics ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 3.79 | 9,000 | 34,110 | 9,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Feb 05 2019 | ACER | Acer Therapeutics ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 24.46 | 6,000 | 146,760 | 6,000 | |
| Feb 05 2019 | ACER | Acer Therapeutics ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 24.46 | 6,000 | 146,760 | 6,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 3.31 | 20,000 | 66,200 | 20,000 | |
| Oct 06 2017 | OPXA | Acer Therapeutics ... | GRIFFIN MICHELLE RENEE | Option Exercise | A | 15.34 | 9,000 | 138,060 | 9,000 | ||
| May 30 2017 | PZRX | PHASERX, INC. | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 1.08 | 14,000 | 15,119 | 14,000 | |
| Jun 03 2016 | PZRX | PHASERX, INC. | GRIFFIN MICHELLE RENEE | Director | Option Exercise | A | 5.08 | 13,631 | 69,245 | 13,631 | |
| May 14 2007 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 5.33 | 17,000 | 90,610 | 17,000 | |
| May 15 2006 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 5.60 | 17,000 | 95,200 | 17,000 | |
| May 24 2005 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 2.87 | 10,000 | 28,700 | 10,000 | |
| May 07 2004 | OGXI | ONCOGENEX PHARMACE ... | BURRIS MICHELLE | Director | Option Exercise | A | 5.69 | 15,000 | 85,350 | 15,000 |
Page: 1